![](/img/cover-not-exists.png)
1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
Hong, D.S., Bang, Y-J., Barlesi, F., Durm, G.A., Falchook, G.S., Govindan, R., Dy, G.K., Park, K., Strickler, J.H., Burns, T.F., Kim, J., Ang, A., Lipford, J.R., Ngarmchamnanrith, G., Anderson, A., LiVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1571
Date:
September, 2020
File:
PDF, 134 KB
2020